Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New vibrating device aims to shake loose mucus in hospital patients

NCT ID NCT07056764

Symptom relief Sponsor: Burapha University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new portable lung vibration device designed to help hospital patients clear mucus from their lungs. Twenty-five adults with trouble coughing up mucus were randomly assigned to receive either standard care or standard care plus the vibration device. The goal was to see if the device improves mucus drainage, vital signs, and reduces treatment time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lung vibration device
What this could lead to
If it works, this device could offer a simple, portable way to help patients clear mucus from their lungs, potentially reducing hospital stays and complications.
What could go wrong
This is a small, early-stage study with only 25 participants, so results may not apply to everyone. The device is still experimental and its benefits over standard care are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

25 people

The number who actually took part.

Started

Feb 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 59 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female * Aged 18-59 years * Inpatients at Burapha University Hospital, Mueang District, Chonburi Province, with pulmonary secretion retention * Referred by their attending physician for enhanced secretion clearance through physical therapy methods Exclusion Criteria: * Having inflamed wounds on the chest or back * Having unstable vital signs, defined as: resting heart rate \<60 or \>100 beats per minute; blood pressure \<90/60 or \>120/80 mmHg; respiratory rate \<12 or \>20 breaths per minute; oxygen saturation \<95%; and body temperature \>37°C * Having a bleeding tendency, defined as a platelet count \<20,000 per cubic millimeter * Taking medications that increase bleeding risk within 7 days prior to participation, including: Anticoagulants (such as Warfarin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban), Antiplatelet agents (such as Aspirin, Clopidogrel, Dipyridamole, Prasugrel, Ticagrelor) * Having an International Normalized Ratio (INR) \>1.1 for those not on anticoagulants, and \>3.0 for those on anticoagulants * Having subcutaneous emphysema * Experiencing severe hemoptysis (coughing up blood) * Having chest wall pain * Having acute spinal cord injury, rib fractures, or conditions associated with high fracture risk * Having skin grafts or burn wounds * Being admitted to intensive care units (ICU, RICU, or CICU) * Having untreated pneumothorax * Having an acute inflammatory process of the respiratory system * Having inflammatory or infectious conditions such as tuberculosis, lung abscess, or COVID-19 * Having respiratory diseases that are contraindications or precautions for lung vibration, including COPD, uncomplicated pneumonia, asthma, lung cancer, or metastatic cancer

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sputum removal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sputum removal

Contacts and locations

Locations

  • Burapha University Hospital

    Mueang, Changwat Chon Buri, 20131, Thailand